{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:14:55Z","timestamp":1788052495541,"version":"build-2784847793"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119162","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:48:20Z","timestamp":1784270900000},"page":"119162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of a novel class of broad-spectrum antivirals targeting the UEV domain of TSG101 in the host ESCRT pathway"],"prefix":"10.1016","volume":"318","author":[{"given":"Daniele","family":"Rubini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Parra-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Holzerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Rodr\u00edguez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Eleonora","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Harty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"P\u00e9rez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0874-6697","authenticated-orcid":false,"given":"Marco","family":"Radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119162_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119162_bib2","volume":"13","author":"Liao","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119162_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ejmech.2026.119162_bib4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.4103\/jfmpc.jfmpc_2071_20","article-title":"Viral pandemics in the past two decades: an overview","volume":"10","author":"Bhadoria","year":"2021","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.ejmech.2026.119162_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.chom.2023.05.012","article-title":"Antiviral strategies for epidemic and pandemic preparedness","volume":"31","author":"Jochmans","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.119162_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119162_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170236","article-title":"Preparing for the next viral threat with broad-spectrum antivirals","volume":"133","author":"Karim","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119162_bib8","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fimmu.2020.02130","article-title":"Viral emerging diseases: challenges in developing vaccination strategies","volume":"11","author":"Trovato","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119162_bib9","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1901594","volume":"382","author":"Feldmann","year":"2020","journal-title":"Ebola, N Engl J Med"},{"key":"10.1016\/j.ejmech.2026.119162_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41541-024-01036-2","article-title":"Establishing an immune correlate of protection for Nipah virus in nonhuman primates","volume":"9","author":"Leyva-Grado","year":"2024","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.ejmech.2026.119162_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116442","article-title":"Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics","volume":"271","author":"L\u00fc","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119162_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116356","article-title":"Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens","volume":"46","author":"Mahajan","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119162_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00168-19","article-title":"Host-directed antiviral therapy","volume":"33","author":"Kumar","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119162_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/JLB.4RI1218-503R","article-title":"Unraveling the host's immune response to infection: seeing is believing","volume":"106","author":"Scott","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2026.119162_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12967-020-02476-9","article-title":"A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals","volume":"18","author":"Chitalia","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119162_bib16","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/med.21664","article-title":"Medicinal chemistry strategies toward host targeting antiviral agents","volume":"40","author":"Ji","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119162_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/microorganisms12030630","article-title":"Exploring viral\u2013host protein interactions as antiviral therapies: a computational perspective","volume":"12","author":"Idrees","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2026.119162_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109346","article-title":"Therapeutic potential of protein\u2013protein interaction modulators in antiviral research","volume":"168","author":"Kaur","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119162_bib19","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3390\/life13091842","article-title":"A review study of the Par4cipa4on of late domains in Sor4ng and transport of viral factors to exosomes","volume":"13","author":"Vel\u00e1zquez-Cervantes","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2026.119162_bib20","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1600-0854.2008.00820.x","article-title":"The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA","volume":"9","author":"Luyet","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.ejmech.2026.119162_bib21","article-title":"Insights into the func4on of ESCRT and its role in enveloped virus infection","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119162_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.chom.2013.08.012","article-title":"Virus budding and the ESCRT pathway","volume":"14","author":"Voteler","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.119162_bib23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/v13081559","article-title":"Importance of viral late domains in budding and release of enveloped RNA viruses","volume":"13","author":"Welker","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119162_bib24","series-title":"Retrovirus-Cell Interactions","first-page":"317","article-title":"Tumor suppressor gene 101","author":"Carter","year":"2018"},{"key":"10.1016\/j.ejmech.2026.119162_bib25","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/emboj\/21.10.2397","article-title":"Structure and functional interactions of the Tsg101 UEV domain","volume":"21","author":"Pornillos","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2026.119162_bib26","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1074\/mcp.M800337-MCP200","article-title":"Proline-rich sequence recognition","volume":"8","author":"Schlundt","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejmech.2026.119162_bib27","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1073\/pnas.0932599100","article-title":"TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation","volume":"100","author":"Lu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119162_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133233","article-title":"Phage display identification of high-affinity ligands for human TSG101-UEV: a structural and thermodynamic study of PTAP recognition","volume":"274","author":"Murciano-Calles","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119162_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/nsb856","article-title":"Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein","author":"Pornillos","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.119162_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(01)00506-2","article-title":"Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding","volume":"107","author":"Garrus","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119162_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1073\/pnas.032511899","article-title":"Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function","volume":"99","author":"Demirov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119162_bib32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm1201-1313","article-title":"HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress","volume":"7","author":"Martin-Serrano","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ejmech.2026.119162_bib33","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1128\/JVI.00476-10","article-title":"Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of marburg virus-like particles","volume":"84","author":"Dolnik","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119162_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004463","article-title":"Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells","volume":"10","author":"Dolnik","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119162_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005659","article-title":"Nipah virus C protein recruits Tsg101 to promote the efficient release of virus in an ESCRT-dependent pathway","volume":"12","author":"Park","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119162_bib36","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1128\/JVI.80.8.4191-4195.2006","article-title":"Cellular factors required for Lassa virus budding","volume":"80","author":"Urata","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119162_bib37","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1002\/anie.200400618","article-title":"Recognition of proline\u2010rich motifs by Protein\u2013Protein\u2010Interaction domains","volume":"44","author":"Ball","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119162_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200302138","article-title":"HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein","volume":"162","author":"Pornillos","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119162_bib39","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.str.2010.08.010","article-title":"Crystallographic and functional analysis of the ESCRT-I\/HIV-1 Gag PTAP interaction","volume":"18","author":"Im","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2026.119162_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(01)03295-1","article-title":"Normalization of nomenclature for peptide motifs as ligands of modular protein domains","volume":"513","author":"Aasland","year":"2002","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejmech.2026.119162_bib41","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/cbic.200800281","article-title":"SAR by oxime\u2010containing peptide libraries: application to Tsg101 ligand optimization","volume":"9","author":"Liu","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2026.119162_bib42","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/ol0622211","article-title":"Hydrazone- and hydrazide-containing N -Substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-Directed HIV-1 budding antagonists","volume":"8","author":"Liu","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119162_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1021\/ml1002579","article-title":"Elucidation of new binding interactions with the human Tsg101 protein using modified HIV-1 Gag-p6 derived peptide ligands","volume":"2","author":"Kim","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119162_bib44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/cb800193n","article-title":"Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag\u2212TSG101 interaction","volume":"3","author":"Tavassoli","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119162_bib45","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1021\/acschembio.9b00627","article-title":"Development of a cyclic peptide inhibitor of the p6\/UEV protein\u2013protein interaction","volume":"14","author":"Lennard","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119162_bib46","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.bbrc.2018.08.079","article-title":"Identification of human immunodeficiency virus type-1 Gag-TSG101 interaction inhibitors by high-throughput screening","volume":"503","author":"Siarot","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.119162_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/341816","article-title":"Bimolecular complementation to visualize filovirus VP40-Host complexes in live mammalian cells: toward the identification of budding inhibitors","volume":"2011","author":"Liu","year":"2011","journal-title":"Adv. Virol."},{"key":"10.1016\/j.ejmech.2026.119162_bib48","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1128\/JVI.03757-13","article-title":"A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress","volume":"88","author":"Lu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119162_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70005","article-title":"Exploring the druggability of the UEV domain of human TSG101 in search for broad-spectrum antivirals","volume":"34","author":"Montero","year":"2025","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.119162_bib50","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.12688\/f1000research.7217.3","article-title":"Machine learning models identify molecules active against the ebola virus in vitro","volume":"4","author":"Ekins","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ejmech.2026.119162_bib51","doi-asserted-by":"crossref","first-page":"40817","DOI":"10.1021\/acsomega.3c05900","article-title":"Synthesis and evaluation of 9-Aminoacridines with SARS-CoV-2 antiviral activity","volume":"8","author":"Jones","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119162_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104863","article-title":"Pyronaridine tetraphosphate efficacy against Ebola virus infection in Guinea pig","volume":"181","author":"Lane","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119162_bib53","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1021\/acsomega.0c05996","article-title":"Repurposing the Ebola and Marburg virus inhibitors tilorone, quinacrine, and pyronaridine: in vitro activity against SARS-CoV-2 and potential mechanisms","volume":"6","author":"Puhl","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119162_bib54","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2017.05.006","article-title":"Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment","volume":"136","author":"Cui","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119162_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bmc.2015.12.011","article-title":"Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment","volume":"24","author":"Cui","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119162_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23398","article-title":"Pyronaridine: an update of its pharmacological activities and mechanisms of action","volume":"112","author":"Bailly","year":"2021","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejmech.2026.119162_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-14001-3","article-title":"Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration","volume":"15","author":"Martina","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119162_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300200","article-title":"Nucleoside derivatives of 2,6\u2010Diaminopurine antivirals: base-modified nucleosides with broad\u2010spectrum antimicrobial properties","volume":"18","author":"Grazia Martina","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119162_bib59","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1039\/D3MD00686G","article-title":"4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections","volume":"15","author":"Barbieri","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119162_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106003","article-title":"Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families","volume":"231","author":"Martina","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119162_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119162_bib62","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1016\/j.tetlet.2013.10.054","article-title":"A one-pot two-step microwave-assisted synthesis of N1-substituted 5,6-ring-fused 2-pyridones","volume":"54","author":"Radi","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2026.119162_bib63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1039\/C5MD00462D","article-title":"A multicomponent pharmacophore fragment-decoration approach to identify selective LRRK2-targeting probes","volume":"7","author":"Tassini","year":"2016","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119162_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202400087","article-title":"A microwave\u2010assisted one\u2010pot three\u2010step metal\u2010free [4+2] annulation for the sustainable synthesis of highly substituted 1,2,4\u2010Triazines","volume":"27","author":"Rubini","year":"2024","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.ejmech.2026.119162_bib65","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.bmcl.2016.06.053","article-title":"Quinoxaline-based inhibitors of ebola and Marburg VP40 egress","volume":"26","author":"Loughran","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119162_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1074-5521(00)00130-7","article-title":"Improving SH3 domain ligand selectivity using a non-natural scaffold","volume":"7","author":"Nguyen","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119162_bib67","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/jiaa174","article-title":"Exosomes facilitate transmission of enterovirus A71 from human intestinal epithelial cells","volume":"222","author":"Huang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119162_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131453","article-title":"Inhibition of ESCRT-independent extracellular vesicles biogenesis suppresses enterovirus 71 replication and pathogenesis in mice","volume":"267","author":"Liang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119162_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105875","article-title":"Enterovirus 71-induced autophagosome fusion with multivesicular bodies facilitates viral RNA packaging into exosomes","volume":"173","author":"Zhang","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejmech.2026.119162_bib70","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1462-5822.2011.01685.x","article-title":"Echovirus 1 infection depends on biogenesis of novel multivesicular bodies: echovirus 1-triggered novel multivesicular bodies","volume":"13","author":"Karjalainen","year":"2011","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119162_bib71","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1128\/JVI.03275-13","article-title":"Coxsackievirus A9 infects cells via nonacidic Multivesicular bodies","volume":"88","author":"Huttunen","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119162_bib72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virusres.2012.07.005","article-title":"Selection and characterisation of guanidine-resistant mutants of human enterovirus 71","volume":"169","author":"Sadeghipour","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.ejmech.2026.119162_bib73","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/acsinfecdis.9b00179","article-title":"Fluoxetine inhibits enterovirus replication by targeting the viral 2C protein in a stereospecific manner","volume":"5","author":"Bauer","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119162_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105177","article-title":"Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species","volume":"195","author":"Lanko","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119162_bib75","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1107\/S0907444906005221","article-title":"Structure of human TSG101 UEV domain","volume":"62","author":"Palencia","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ejmech.2026.119162_bib76","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(89)90602-7","article-title":"Calculation of protein extinction coefficients from amino acid sequence data","volume":"182","author":"Gill","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2026.119162_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167372","article-title":"HTSDSF explorer, A novel tool to analyze high-throughput DSF screenings","volume":"434","author":"Martin-Malpartida","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.119162_bib78","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/JVI.77.3.1812-1819.2003","article-title":"Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4","volume":"77","author":"Licata","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119162_bib79","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1021\/ci800166p","article-title":"Lead finder: an approach to improve accuracy of protein\u2212ligand docking, binding energy estimation, and virtual screening","volume":"48","author":"Stroganov","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119162_bib80","first-page":"1","article-title":"Enhancing MD simulations: asgard's automated analysis for GROMACS","author":"Rodr\u00edguez-Mart\u00ednez","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2026.119162_bib81","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ct7000045","article-title":"Validation of molecular dynamics simulations of biomolecules using NMR spin relaxation as benchmarks: application to the AMBER99SB force field","volume":"3","author":"Showalter","year":"2007","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejmech.2026.119162_bib82","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/v14051044","article-title":"Assessment of life cycle modeling systems as prediction tools for a possible attenuation of recombinant Ebola viruses","volume":"14","author":"Bodmer","year":"2022","journal-title":"Viruses"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:15:34Z","timestamp":1788048934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":82,"alternative-id":["S0223523426006070"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119162","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel class of broad-spectrum antivirals targeting the UEV domain of TSG101 in the host ESCRT pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119162"}}